Marc Carig of Newsday reported that some teams had expressed interest in buying low on RHP Matt Harvey before the trade deadline.
Harvey, 28, is currently rehabbing a scapula bone injury and is close to returning to the Major Leagues barring any setbacks.
After posting a 2.53 ERA, 2.65 FIP and 9.5 K/9 in his first three seasons (2012, 2013 and 2015), Harvey regressed significantly in 2016 going 4-10 with a 4.86 ERA and 3.47 FIP before needing surgery to alleviate thoracic outlet syndrome. After having a rib removed this past offseason, Harvey has been even worse in 2017 having gone 4-3 with a 5.25 ERA and 6.18 FIP in 13 starts.
The Mets hope he can still rebound after this latest round of rehab, and it seems that the teams looking to buy low on him this July thought the same. It remains to be seen if he will regain his dominant stuff or close to it this or next season, but the Mets did not risk losing much by not selling him to low-balling teams this July.
